These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18291403)

  • 21. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice.
    Moura R; Tjwa M; Vandervoort P; Van Kerckhoven S; Holvoet P; Hoylaerts MF
    Circ Res; 2008 Nov; 103(10):1181-9. PubMed ID: 18818405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-145 targeted therapy reduces atherosclerosis.
    Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
    Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Low Carbohydrate High Protein (LCHP) diet on atherosclerotic plaque phenotype in ApoE/LDLR-/- mice: FT-IR and Raman imaging.
    Wrobel TP; Marzec KM; Chlopicki S; Maślak E; Jasztal A; Franczyk-Żarów M; Czyżyńska-Cichoń I; Moszkowski T; Kostogrys RB; Baranska M
    Sci Rep; 2015 Sep; 5():14002. PubMed ID: 26391802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there life after plaque rupture?
    Jackson CL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):887-9. PubMed ID: 17956238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenomedullin ameliorates the development of atherosclerosis in apoE-/- mice.
    Pan CS; Zhang J; Yu F; Teng X; Cao CQ; Wu W; Tang CS; Qi YF
    Peptides; 2010 Jun; 31(6):1150-8. PubMed ID: 20332006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
    Kuzuya M; Nakamura K; Sasaki T; Cheng XW; Itohara S; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1120-5. PubMed ID: 16556856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse.
    Williams H; Pease RJ; Newell LM; Cordell PA; Graham RM; Kearney MT; Jackson CL; Grant PJ
    Atherosclerosis; 2010 May; 210(1):94-9. PubMed ID: 20003977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
    Gregersen H; Zhao J; Lu X; Zhou J; Falk E
    Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational stress analysis of atherosclerotic plaques in ApoE knockout mice.
    Vengrenyuk Y; Kaplan TJ; Cardoso L; Randolph GJ; Weinbaum S
    Ann Biomed Eng; 2010 Mar; 38(3):738-47. PubMed ID: 20336835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice.
    Williams H; Johnson JL; Carson KG; Jackson CL
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):788-92. PubMed ID: 12006391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous atherothrombosis and medial degradation in Apoe-/-, Npc1-/- mice.
    Welch CL; Sun Y; Arey BJ; Lemaitre V; Sharma N; Ishibashi M; Sayers S; Li R; Gorelik A; Pleskac N; Collins-Fletcher K; Yasuda Y; Bromme D; D'Armiento JM; Ogletree ML; Tall AR
    Circulation; 2007 Nov; 116(21):2444-52. PubMed ID: 17984379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method of plaque rupture induction in apolipoprotein E-deficient mice.
    Sasaki T; Kuzuya M; Nakamura K; Cheng XW; Shibata T; Sato K; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1304-9. PubMed ID: 16574894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.
    Coleman R; Hayek T; Keidar S; Aviram M
    Acta Histochem; 2006; 108(6):415-24. PubMed ID: 17007910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions.
    Bond AR; Hultgårdh-Nilsson A; Knutsson A; Jackson CL; Rauch U
    Atherosclerosis; 2014 Oct; 236(2):366-72. PubMed ID: 25133350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.